Related references
Note: Only part of the references are listed.Oxidized HDL Is Associated With Biomarkers of Inflammation and Immune Activation in Untreated and Treated HIV Infection
Theodoros Kelesidis et al.
Open Forum Infectious Diseases (2017)
Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV
Eric Nou et al.
AIDS (2016)
Statins to improve cardiovascular outcomes in treated HIV infection
Chris T. Longenecker et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2016)
Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration
Anna Maisa et al.
AIDS (2015)
Characterization of Lipid Composition and High-Density Lipoprotein Function in HIV-Infected Individuals on Stable Antiretroviral Regimens
Alana M. Munger et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2015)
A Systematic Review of the Usefulness of Statin Therapy in HIV-Infected Patients
Matthew J. Feinstein et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Ceramide Is Upregulated and Associated With Mortality in Patients With Chronic Heart Failure
Jingjia Yu et al.
CANADIAN JOURNAL OF CARDIOLOGY (2015)
Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis
Taufiq Salahuddin et al.
EUROPEAN HEART JOURNAL (2015)
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation
David A. Zidar et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
Rosuvastatin Reduces Vascular Inflammation and T-cell and Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy
Nicholas T. Funderburg et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
Fatty acyl composition of lysophosphatidylcholine is important in atherosclerosis
O. A. Akerele et al.
MEDICAL HYPOTHESES (2015)
The Association Between Reduction in Inflammation and Changes in Lipoprotein Levels and HDL Cholesterol Efflux Capacity in Rheumatoid Arthritis
Katherine P. Liao et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Cholesterol, inflammation and innate immunity
Alan R. Tall et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection
Chris T. Longenecker et al.
AIDS (2014)
Rosuvastatin Treatment Reduces Markers of Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy
Nicholas T. Funderburg et al.
CLINICAL INFECTIOUS DISEASES (2014)
Rosuvastatin Preserves Renal Function and Lowers Cystatin C in HIV-Infected Subjects on Antiretroviral Therapy: The SATURN-HIV Trial
Chris T. Longenecker et al.
CLINICAL INFECTIOUS DISEASES (2014)
Effect of 24 Weeks of Statin Therapy on Systemic and Vascular Inflammation in HIV-Infected Subjects Receiving Antiretroviral Therapy
Allison Ross Eckard et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Sevelamer Does Not Decrease Lipopolysaccharide or Soluble CD14 Levels But Decreases Soluble Tissue Factor, Low-Density Lipoprotein (LDL) Cholesterol, and Oxidized LDL Cholesterol Levels in Individuals With Untreated HIV Infection
Netanya G. Sandler et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Diets High in Protein or Saturated Fat Do Not Affect Insulin Sensitivity or Plasma Concentrations of Lipids and Lipoproteins in Overweight and Obese Adults
Sally Chiu et al.
JOURNAL OF NUTRITION (2014)
HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
Anand Rohatgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Plasma lipidomic analysis predicts non-calcified coronary artery plaque in asymptomatic patients at intermediate risk of coronary artery disease
Andris H. Ellims et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2014)
Metabolic Consequences of HIV: Pathogenic Insights
Amanda L. Willig et al.
CURRENT HIV/AIDS REPORTS (2014)
Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals
Stefania Piconi et al.
AIDS (2013)
Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events
Antonella d'Arminio Monforte et al.
AIDS (2013)
Perivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapy
Chris T. Longenecker et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Three Distinct Phases of HIV-1 RNA Decay in Treatment-Naive Patients Receiving Raltegravir-Based Antiretroviral Therapy: ACTG A5248
Adriana Andrade et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Plasma lipid profiling in a large population-based cohort
Jacquelyn M. Weir et al.
JOURNAL OF LIPID RESEARCH (2013)
Metabolic disease in HIV infection
Jordan E. Lake et al.
LANCET INFECTIOUS DISEASES (2013)
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
Frederick J. Sheedy et al.
NATURE IMMUNOLOGY (2013)
IL-1B Enriched Monocytes Mount Massive IL-6 Responses to Common Inflammatory Triggers among Chronically HIV-1 Infected Adults on Stable Anti-Retroviral Therapy at Risk for Cardiovascular Disease
Emilie Jalbert et al.
PLOS ONE (2013)
Dynamics of Immune Reconstitution and Activation Markers in HIV plus Treatment-Naive Patients Treated with Raltegravir, Tenofovir Disoproxil Fumarate and Emtricitabine
Nicholas T. Funderburg et al.
PLOS ONE (2013)
Changes in Lipoprotein-Associated Phospholipase A2 Activity Predict Coronary Events and Partly Account for the Treatment Effect of Pravastatin: Results From the Long-term Intervention with Pravastatin in Ischemic Disease Study
Harvey D. White et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
LDL subclasses and lipoprotein-phospholipase A2 activity in suppressed HIV-infected patients switching to raltegravir: Spiral substudy
Maria Saumoy et al.
ATHEROSCLEROSIS (2012)
Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis
Nehal N. Mehta et al.
ATHEROSCLEROSIS (2012)
Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome
Nicholas T. Funderburg et al.
BLOOD (2012)
Small Dense Lipoproteins, Apolipoprotein B, and Risk of Coronary Events in HIV-Infected Patients on Antiretroviral Therapy: The Swiss HIV Cohort Study
Heiner C. Bucher et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Arterial Inflammation in Patients With HIV
Sharath Subramanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin
A. Phillip Owens et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The not-so-simple HDL story Is it time to revise the HDL cholesterol hypothesis?
Daniel J. Rader et al.
NATURE MEDICINE (2012)
Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy
Jason V. Baker et al.
AIDS (2011)
Oxidized LDL, LOX-1 and Atherosclerosis
Sona Mitra et al.
CARDIOVASCULAR DRUGS AND THERAPY (2011)
Soluble CD163, a Novel Marker of Activated Macrophages, Is Elevated and Associated With Noncalcified Coronary Plaque in HIV-Infected Patients
Tricia H. Burdo et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
Netanya G. Sandler et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
Amit V. Khera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation
Nicholas T. Funderburg et al.
BLOOD (2010)
Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation
S. Parra et al.
HIV MEDICINE (2010)
Changes in Lipids and Lipoprotein Particle Concentrations After Interruption of Antiretroviral Therapy
Fiona C. Lampe et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
Cameron R. Stewart et al.
NATURE IMMUNOLOGY (2010)
Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
Kristiina Rajamaki et al.
PLOS ONE (2010)
Lipoprotein particle subclasses, cardiovascular disease and HIV infection
Daniel A. Duprez et al.
ATHEROSCLEROSIS (2009)
Inflammation Impairs Reverse Cholesterol Transport In Vivo
Fiona C. McGillicuddy et al.
CIRCULATION (2009)
Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction
Virginia A. Triant et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Relationship of lipoprotein-associated phospholipase A(2) and oxidized low density lipoprotein in carotid atherosclerosis
Kasey C. Vickers et al.
JOURNAL OF LIPID RESEARCH (2009)
Update on strategies to increase HDL quantity and function
Danielle Duffy et al.
NATURE REVIEWS CARDIOLOGY (2009)
Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy
Giulia Marchetti et al.
AIDS (2008)
Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men
Robert C. Kaplan et al.
AIDS (2008)
Thromboses among HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era
Nancy F. Crum-Cianflone et al.
AIDS PATIENT CARE AND STDS (2008)
Human Immunodeficiency Virus Infection and Risk of Venous Thromboembolism
Fadi Matta et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2008)
HIV infection and high density lipoprotein metabolism
Honor Rose et al.
ATHEROSCLEROSIS (2008)
HDL, ABC transporters, and cholesterol efflux: Implications for the treatment of atherosclerosis
Alan R. Tall et al.
CELL METABOLISM (2008)
Serum N-3 Polyunsaturated Fatty Acid Levels Correlate With the Extent of Coronary Plaques and Calcifications in Patients With Acute Myocardial Infarction
Masayuki Ueeda et al.
CIRCULATION JOURNAL (2008)
High prevalence of peripheral arterial disease in HIV-infected persons
Daniel Periard et al.
CLINICAL INFECTIOUS DISEASES (2008)
HIV and antiretroviral therapy: Lipid abnormalities and associated cardiovascular risk in HIV-infected patients
Donald P. Kotler
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study
Sean Emery et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
Matthew J. McQueen et al.
LANCET (2008)
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
Lewis H. Kuller et al.
PLOS MEDICINE (2008)
Aging up-regulates expression of inflammatory mediators in mouse adipose tissue
Dayong Wu et al.
JOURNAL OF IMMUNOLOGY (2007)
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease
Virginia A. Triant et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Class of antiretroviral drugs and the risk of myocardial infarction
Nina Friis-Moller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
CD36 is a receptor for oxidized high density lipoprotein: Implications for the development of atherosclerosis
Rick F. Thorne et al.
FEBS LETTERS (2007)
Stent thrombosis in randomized clinical trials of drug-eluting stents
Laura Mauri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Risk of cardiovascular disease in a cohort of HIV-Infected adults: A study using carotid intima-media thickness and coronary artery calcium score
Alexandra Mangili et al.
CLINICAL INFECTIOUS DISEASES (2006)
Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses
Priscilla Y. Hsue et al.
AIDS (2006)
Role of tissue factor in hemostasis and thrombosis
N Mackman
BLOOD CELLS MOLECULES AND DISEASES (2006)
Concentration of circulating oxidized LDL in HIV-infected patients treated with antiretroviral agents: Relation to HIV-related lipodystrophy
M Duong et al.
HIV CLINICAL TRIALS (2006)
Mechanisms of disease: atherosclerosis in autoimmune diseases
Y Sherer et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease
S Tsimikas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Impaired monocyte maturation in response to CpG oligodeoxynucleotide is related to viral RNA levels in human immunodeficiency virus disease and is at least partially mediated by deficiencies in alpha/beta interferon responsiveness and production
W Jiang et al.
JOURNAL OF VIROLOGY (2005)
Medical progress - Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
S Grinspoon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection
PY Hsue et al.
CIRCULATION (2004)
Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans
SL Fultz et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection
PY Hsue et al.
CIRCULATION (2004)
Cardio- and cerebrovascular events in HIV-infected persons
AD Monforte et al.
AIDS (2004)
Cardiovascular disease risk factors in HIV patients -: association with antiretroviral therapy.: Results from the DAD study
N Friis-Moller et al.
AIDS (2003)
Atherosclerosis and HIV in the highly active antiretroviral therapy era: towards an epidemic of cardiovascular disease?
V Mooser
AIDS (2003)
Oxidized LDL in carotid plaques and plasma associates with plaque instability
K Nishi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Oxidized LDL and HDL: antagonists in atherothrombosis
A Mertens et al.
FASEB JOURNAL (2001)
Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells
DY Li et al.
CIRCULATION (2000)
Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells - Evidence from use of antisense LOX-1 mRNA and chemical inhibitors
DY Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patients
A Tabib et al.
CORONARY ARTERY DISEASE (2000)
Share Paper
